{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:37:34Z","timestamp":1773977854204,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s40257-019-00430-0","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T12:03:14Z","timestamp":1553515394000},"page":"515-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Childhood Vitiligo"],"prefix":"10.1007","volume":"20","author":[{"given":"Electra","family":"Nicolaidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-5497","authenticated-orcid":false,"given":"Styliani","family":"Mastraftsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Tzanetakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"430_CR1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"C Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol. 2012;51:1206\u201312.","journal-title":"Int J Dermatol"},{"key":"430_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2310\/7750.2012.12005","volume":"17","author":"N Malhotra","year":"2013","unstructured":"Malhotra N, Dytoc M. The pathogenesis of vitiligo. J Cutan Med Surg. 2013;17:153\u201372.","journal-title":"J Cutan Med Surg"},{"key":"430_CR3","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T, et al. Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1\u201313.","journal-title":"Pigment Cell Melanoma Res"},{"key":"430_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jaad.2011.07.010","volume":"66","author":"E Nicolaidou","year":"2012","unstructured":"Nicolaidou E, Antoniou C, Miniati A, Lagogianni E, Matekovits A, Stratigos A, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol. 2012;66:954\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1365-2133.2012.11002.x","volume":"167","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Diallo A, L\u00e9aut\u00e9-Labr\u00e8ze C, et al. Pre- vs. post-pubertal onset of\u00a0vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset\u00a0vitiligo. Br J Dermatol. 2012;167:490\u20135.","journal-title":"Br J Dermatol."},{"key":"430_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/pde.12032","volume":"30","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Gupta S, Ojha A, Sinha R. Childhood vitiligo: clinicoepidemiologic profile of 268 children from Kumaun region of Uttarakhand, India. Pediatr Dermatol. 2013;30:348\u201353.","journal-title":"Pediatr Dermatol"},{"key":"430_CR7","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S0190-9622(87)70119-4","volume":"16","author":"RM Halder","year":"1987","unstructured":"Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA. Childhood vitiligo. J Am Acad Dermatol. 1987;16:948\u201354.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1525-1470.2000.01749.x","volume":"17","author":"S Cho","year":"2000","unstructured":"Cho S, Kang H-C, Hahm J-H. Characteristics of vitiligo in Korean children. Pediatr Dermatol. 2000;17:189\u201393.","journal-title":"Pediatr Dermatol"},{"key":"430_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","volume":"113","author":"J Howitz","year":"1977","unstructured":"Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo. Epidemiological survey of the Isle of Bornholm, Denmark. Arch Dermatol. 1977;113:47\u201352.","journal-title":"Arch Dermatol"},{"key":"430_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2340\/00015555-1397","volume":"93","author":"X Wang","year":"2013","unstructured":"Wang X, Du J, Wang T, et al. Prevalence and clinical profile of vitiligo in China: a community-based study in six cities. Acta Derm Venereol. 2013;93:62\u20135.","journal-title":"Acta Derm Venereol"},{"key":"430_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1525-1470.2003.20304.x","volume":"20","author":"S Handa","year":"2003","unstructured":"Handa S, Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from North India. Pediatr Dermatol. 2003;20:207\u201310.","journal-title":"Pediatr Dermatol"},{"key":"430_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1525-1470.2006.00192.x","volume":"23","author":"Z Hu","year":"2006","unstructured":"Hu Z, Liu J-B, Ma S-S, Yang S, Zhan XJ. Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol. 2006;23:114\u20136.","journal-title":"Pediatr Dermatol"},{"key":"430_CR13","first-page":"1096","volume":"17","author":"S Marinho Fde","year":"2013","unstructured":"Marinho Fde S, Cirino PV, Fernandes NC. Clinical epidemiological profile of vitiligo in children and adolescents. An Bras Dermatol. 2013;17:1096\u20139.","journal-title":"An Bras Dermatol"},{"key":"430_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jaad.2015.05.038","volume":"73","author":"EW Mu","year":"2015","unstructured":"Mu EW, Cohen BE, Orlow SJ. Early-onset childhood vitiligo is associated with a more extensive and progressive course. J Am Acad Dermatol. 2015;73:467\u201370.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaad.2006.02.027","volume":"55","author":"U Pajvani","year":"2006","unstructured":"Pajvani U, Ahmad N, Wiley A, Levy RM, et al. The relationship between family medical history and childhood vitiligo. J Am Acad Dermatol. 2006;55:238\u201344.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1525-1470.2011.01478.x","volume":"29","author":"K A-Refu","year":"2012","unstructured":"A-Refu K. Vitiligo in children: a clinical-epidemiologic study in Jordan. Pediatr Dermatol. 2012;29:114\u20135.","journal-title":"Pediatr Dermatol"},{"key":"430_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, et al. Vitiligo: a comprehensive overview: Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65:473\u201391.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jaad.2015.12.049","volume":"74","author":"EY Gan","year":"2016","unstructured":"Gan EY, Cario-Andr\u00e9 M, Pain C, et al. Follicular vitiligo: a report of 8 cases. J Am Acad Dermatol. 2016;74:1178\u201384.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/pde.12226","volume":"31","author":"JI Silverberg","year":"2014","unstructured":"Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014;31:309\u201318.","journal-title":"Pediatr Dermatol"},{"key":"430_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jaad.2010.08.031","volume":"65","author":"K Ezzedine","year":"2011","unstructured":"Ezzedine K, Gauthier Y, L\u00e9aut\u00e9-Labr\u00e8ze C, et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol. 2011;65:965\u201371.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2133.2011.10709.x","volume":"166","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Diallo A, L\u00e9aut\u00e9-Labr\u00e8ze C, et al. Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Br J Dermatol. 2012;166:539\u201344.","journal-title":"Br J Dermatol"},{"key":"430_CR22","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1111\/j.1468-3083.2012.04491.x","volume":"27","author":"I Neri","year":"2013","unstructured":"Neri I, Russo T, Piccolo V, Patrizi A. Mixed vitiligo in childhood: a study on 13 Italian patients. J Eur Acad Dermatol Venereol. 2013;27:e140\u20131.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"430_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/bjd.13423","volume":"172","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Mah\u00e9 A, van Geel N, et al. Hypochromic vitiligo: delineation of a new entity. Br J Dermatol. 2015;172:716\u201321.","journal-title":"Br J Dermatol"},{"key":"430_CR24","doi-asserted-by":"publisher","first-page":"e20154126","DOI":"10.1542\/peds.2015-4126","volume":"138","author":"K Ezzedine","year":"2016","unstructured":"Ezzedine K, Silverberg N. A practical approach to the diagnosis and treatment of vitiligo in children. Pediatrics. 2016;138:e20154126.","journal-title":"Pediatrics"},{"key":"430_CR25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2009.06.081","volume":"62","author":"J Mazereeuw-Hautier","year":"2010","unstructured":"Mazereeuw-Hautier J, Bezio S, Mahe E, et al. Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. J Am Acad Dermatol. 2010;62:945\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"430_CR26","doi-asserted-by":"publisher","first-page":"e12420","DOI":"10.1111\/dth.12420","volume":"30","author":"T Anbar","year":"2017","unstructured":"Anbar T, Abdel-Rahman A, Hegazy R, El-Khayyat M, Ragale M. Simultaneous improvement and worsening of vitiligo lesions during the course of NB-UVB phototherapy; vitiligo may not act as one unit. Dermatol Ther. 2017;30(1):e12420.","journal-title":"Dermatol Ther"},{"key":"430_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pcl.2013.11.008","volume":"61","author":"NB Silverberg","year":"2014","unstructured":"Silverberg NB. Pediatric vitiligo. Pediatr Clin N Am. 2014;61:347\u201366.","journal-title":"Pediatr Clin N Am"},{"key":"430_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","volume":"18","author":"G Laberge","year":"2005","unstructured":"Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005;18:300\u20135.","journal-title":"Pigment Cell Res"},{"key":"430_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/jdv.12169","volume":"28","author":"N Geel van","year":"2014","unstructured":"van Geel N, Speeckaert M, Brochez L, et al. Clinical profile of generalized vitiligo patients with associated autoimmune\/autoinflammatory diseases. J Eur Acad Dermatol Venereol. 2014;28:741\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"430_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000081479","volume":"210","author":"P Iacovelli","year":"2005","unstructured":"Iacovelli P, Sinagra JL, Vidolin AP, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005;210:26\u201330.","journal-title":"Dermatology"},{"key":"430_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jaad.2005.03.032","volume":"53","author":"T Kakourou","year":"2005","unstructured":"Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, et al. Increased prevalence of chronic autoimmune (Hashimoto\u2019s) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;53:220\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5114\/ada.2016.60617","volume":"33","author":"D Kartal","year":"2016","unstructured":"Kartal D, Borlu M, \u04aainar SL, et al. Thyroid abnormalities in paediatric patients with vitiligo: retrospective study. Postepy Dermatol Alergol. 2016;33:232\u20134.","journal-title":"Postepy Dermatol Alergol"},{"key":"430_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1468-3083.2010.03694.x","volume":"25","author":"SB Cho","year":"2011","unstructured":"Cho SB, Kim JH, Cho S, et al. Vitiligo in children and adolescents: association with thyroid dysfunction. J Eur Acad Dermatol Venereol. 2011;25:64\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"430_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/pde.12717","volume":"33","author":"BE Cohen","year":"2016","unstructured":"Cohen BE, Mu EW, Orlow SJ. Comparison of childhood vitiligo presenting with or without associated halo nevi. Pediatr Dermatol. 2016;33:44\u20138.","journal-title":"Pediatr Dermatol"},{"key":"430_CR35","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1111\/j.1468-3083.2012.04504.x","volume":"27","author":"A Patrizi","year":"2013","unstructured":"Patrizi A, Bentivogli M, Raone B, et al. Association of halo nevus\/i and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol. 2013;27:e148\u201352.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"430_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archdermatol.2011.351","volume":"148","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Diallo A, L\u00e9aut\u00e9-Labr\u00e8ze C, et al. Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Arch Dermatol. 2012;148:497\u2013502.","journal-title":"Arch Dermatol"},{"key":"430_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2230.2010.03965.x","volume":"36","author":"O Bilgi\u00e7","year":"2011","unstructured":"Bilgi\u00e7 O, Bilgi\u00e7 A, Aki\u015f HK, et al. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol. 2011;36:360\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"430_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-4632.2012.05656.x","volume":"53","author":"C Kr\u00fcger","year":"2014","unstructured":"Kr\u00fcger C, Panske A, Schallreuter KU. Disease-related behavioral patterns and experiences affect quality of life in children and adolescents with vitiligo. Int J Dermatol. 2014;53:43\u201350.","journal-title":"Int J Dermatol"},{"key":"430_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000448656","volume":"232","author":"J Catucci Boza","year":"2016","unstructured":"Catucci Boza J, Giongo N, Machado P, et al. Quality of life impairment in children and adults with vitiligo: a cross-sectional study based on dermatology-specific and disease-specific quality of life instruments. Dermatology. 2016;232:619\u201325.","journal-title":"Dermatology"},{"key":"430_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2340\/00015555-1940","volume":"95","author":"AA Amer","year":"2015","unstructured":"Amer AA, Mchepange UO, Gao XH, et al. Hidden victims of childhood vitiligo: impact on parents\u2019 mental health and quality of life. Acta Derm Venereol. 2015;95:322\u20135.","journal-title":"Acta Derm Venereol"},{"key":"430_CR41","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1590\/abd1806-4841.20131915","volume":"88","author":"AP Manzoni","year":"2013","unstructured":"Manzoni AP, Weber MB, Nagatomi AR, et al. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders. An Bras Dermatol. 2013;88:894\u20139.","journal-title":"An Bras Dermatol"},{"key":"430_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u04e7hm M, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168:5\u201319.","journal-title":"Br J Dermatol"},{"key":"430_CR43","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","volume":"159","author":"DJ Gawkrodger","year":"2008","unstructured":"Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159:1051\u201376.","journal-title":"Br J Dermatol"},{"key":"430_CR44","first-page":"344","volume":"16","author":"S Zabetian","year":"2017","unstructured":"Zabetian S, Jacobson J, Lim HW, Eide MJ, Huggins RH. Quality of life in a\u00a0vitiligo\u00a0support group. J Drugs Dermatol. 2017;16:344\u201350.","journal-title":"J Drugs Dermatol"},{"key":"430_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0974-2077.112665","volume":"6","author":"N Geel van","year":"2013","unstructured":"van Geel N, Speeckaert M, Chevolet I, et al. Hypomelanoses in children. J Cutan Aesthet Surg. 2013;6:65\u201372.","journal-title":"J Cutan Aesthet Surg"},{"key":"430_CR46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jaad.2014.07.029","volume":"71","author":"ML Ramien","year":"2014","unstructured":"Ramien ML, Ondrejchak S, Gendron R, et al. Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions. J Am Acad Dermatol. 2014;71:935\u201340.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1203475415595175","volume":"20","author":"JM Salsberg","year":"2016","unstructured":"Salsberg JM, Weinstein M, Shear N, et al. Impact of cosmetic camouflage on the quality of life of children with skin disease and their families. J Cutan Med Surg. 2016;20:211\u20135.","journal-title":"J Cutan Med Surg"},{"key":"430_CR48","first-page":"110","volume":"79","author":"A Tedeschi","year":"2007","unstructured":"Tedeschi A, Dall\u2019Oglio F, Micali G, et al. Corrective camouflage in pediatric dermatology. Cutis. 2007;79:110\u20132.","journal-title":"Cutis"},{"key":"430_CR49","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaad.2006.08.017","volume":"56","author":"J Kwinter","year":"2007","unstructured":"Kwinter J, Pelletier J, Khambalia A, et al. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol. 2007;56:236\u201341.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR50","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1365-2133.2011.10351.x","volume":"165","author":"N Ho","year":"2011","unstructured":"Ho N, Pope E, Weinstein M, et al. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. Br J Dermatol. 2011;165:626\u201332.","journal-title":"Br J Dermatol"},{"key":"430_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/09546630903266761","volume":"21","author":"O K\u04e7se","year":"2010","unstructured":"K\u04e7se O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. J Dermatolog Treat. 2010;21:133\u20139.","journal-title":"J Dermatolog Treat"},{"key":"430_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, et al. Current and emerging treatments for vitiligo. J Am Acad Dermatol. 2017;77:17\u201329.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR53","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2006.09.004","volume":"56","author":"E Nicolaidou","year":"2007","unstructured":"Nicolaidou E, Antoniou C, Stratigos AJ, Stefanaki C, Katsambas AD. Efficacy, predictors of response and long-term follow-up in vitiligo patients treated with narrow band UVB phototherapy. J Am Acad Dermatol. 2007;56:274\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR54","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jaad.2008.07.053","volume":"60","author":"E Nicolaidou","year":"2009","unstructured":"Nicolaidou E, Antoniou C, Stratigos A, et al. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review. J Am Acad Dermatol. 2009;60:470\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR55","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1525-1470.2011.01683.x","volume":"29","author":"S Percivalle","year":"2012","unstructured":"Percivalle S, Piccinno R, Caccialanza M, et al. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients. Pediatr Dermatol. 2012;29:160\u20135.","journal-title":"Pediatr Dermatol"},{"key":"430_CR56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","volume":"42","author":"MD Njoo","year":"2000","unstructured":"Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42:245\u201353.","journal-title":"J Am Acad Dermatol"},{"key":"430_CR57","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2230.2005.01837.x","volume":"30","author":"AJ Kanwar","year":"2005","unstructured":"Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30:332\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"430_CR58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.det.2016.11.003","volume":"35","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues M. Skin cancer risk (nonmelanoma skin cancers\/melanoma) in vitiligo patients. Dermatol Clin. 2017;35:129\u201334.","journal-title":"Dermatol Clin"},{"key":"430_CR59","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.jid.2018.03.1511","volume":"138","author":"W Wu","year":"2018","unstructured":"Wu W, the 23andMe Research Team, Amos CI, et al. Inverse relationship between vitiligo-related genes and skin cancer. J Invest Dermatol. 2018;138:2072\u20135.","journal-title":"J Invest Dermatol"},{"key":"430_CR60","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1365-2133.2008.08776.x","volume":"159","author":"RM Hearn","year":"2008","unstructured":"Hearn RM, Kerr AC, Rahim KF, et al. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol. 2008;159:931\u20135.","journal-title":"Br J Dermatol"},{"key":"430_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09546630802155057","volume":"20","author":"I Esfandiarpour","year":"2009","unstructured":"Esfandiarpour I, Ekhlasi A, Farajzadeh S, et al. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatolog Treat. 2009;20:14\u20138.","journal-title":"J Dermatolog Treat"},{"key":"430_CR62","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0781.2010.00540.x","volume":"26","author":"I Majid","year":"2010","unstructured":"Majid I. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol Photoimmunol Photomed. 2010;26:230\u20134.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"430_CR63","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/dth.12295","volume":"29","author":"YP Dang","year":"2016","unstructured":"Dang YP, Li Q, Shi F, Yuan XY, Liu W. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta-analysis. Dermatol Ther. 2016;29:126\u201333.","journal-title":"Dermatol Ther"},{"key":"430_CR64","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/pde.12991","volume":"33","author":"S Dayal","year":"2016","unstructured":"Dayal S, Sahu P, Gupta N. Treatment of childhood vitiligo using tacrolimus ointment with narrowband ultraviolet B phototherapy. Pediatr Dermatol. 2016;33:646\u201351.","journal-title":"Pediatr Dermatol"},{"key":"430_CR65","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.4081\/dr.2010.e13","volume":"2","author":"CM Lerche","year":"2010","unstructured":"Lerche CM, Wulf HC. Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs. Dermatol Rep. 2010;2:e13.","journal-title":"Dermatol Rep"},{"key":"430_CR66","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40257-013-0020-1","volume":"14","author":"EC Siegfried","year":"2013","unstructured":"Siegfried EC, Jaworski JC, Hebert A. Topical calcineurin inhibitors and lymphoma risk: evidence update with implication for daily practice. Am J Clin Dermatol. 2013;14:163\u201378.","journal-title":"Am J Clin Dermatol"},{"key":"430_CR67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1600-0781.2010.00558.x","volume":"27","author":"S Cho","year":"2011","unstructured":"Cho S, Zheng Z, Park YK, et al. The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatol Photoimmunol Photomed. 2011;27:24\u20139.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"430_CR68","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/pde.12506","volume":"32","author":"MJ Koh","year":"2015","unstructured":"Koh MJ, Mok ZR, Chong WS. Phototherapy for the treatment of vitiligo in Asian children. Pediatr Dermatol. 2015;32:192\u20137.","journal-title":"Pediatr Dermatol"},{"key":"430_CR69","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","volume":"26","author":"Y Hui-Lan","year":"2009","unstructured":"Hui-Lan Y, Xiao-Yan H, Jian-Yong F, et al. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol. 2009;26:354\u20136.","journal-title":"Pediatr Dermatol"},{"key":"430_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/09546634.2010.543122","volume":"23","author":"JJ Hu","year":"2012","unstructured":"Hu JJ, Xu AE, Wu XG, et al. Small-sized lesions of childhood vitiligo treated by autologous epidermal grafting. J Dermatolog Treat. 2012;23:219\u201323.","journal-title":"J Dermatolog Treat"},{"key":"430_CR71","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2230.2011.04065.x","volume":"36","author":"K Sahni","year":"2011","unstructured":"Sahni K, Parsad D, Kanwar AJ. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents. Clin Exp Dermatol. 2011;36:607\u201312.","journal-title":"Clin Exp Dermatol"},{"key":"430_CR72","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1525-1470.2009.00978.x","volume":"27","author":"SV Mulekar","year":"2010","unstructured":"Mulekar SV, Al Eisa A, Delvi MB, et al. Childhood vitiligo: a long-term study of localized vitiligo treated by noncultured cellular grafting. Pediatr Dermatol. 2010;27:132\u20136.","journal-title":"Pediatr Dermatol"},{"key":"430_CR73","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1468-3083.2010.03824.x","volume":"25","author":"WS Hong","year":"2011","unstructured":"Hong WS, Hu DN, Qian GP, et al. Treatment of vitiligo in children and adolescents by autologous cultured pure melanocytes transplantation with comparison of efficacy to results in adults. J Eur Acad Dermatol Venereol. 2011;25:538\u201343.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"430_CR74","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1468-3083.2011.04097.x","volume":"26","author":"L Yao","year":"2012","unstructured":"Yao L, Li SS, Zhong SX, et al. Successful treatment of vitiligo on the axilla in a 5-year-old child by cultured-melanocyte transplantation. J Eur Acad Dermatol Venereol. 2012;26:658\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"430_CR75","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1111\/pde.13016","volume":"34","author":"XG Wu","year":"2017","unstructured":"Wu XG, Xu AE. Successful treatment of vitiligo on the scalp of a 9-year-old girl using autologous cultured pure melanocyte transplantation. Pediatr Dermatol. 2017;34:e22\u20133.","journal-title":"Pediatr Dermatol"},{"key":"430_CR76","first-page":"1","volume":"9","author":"SS Awad","year":"2018","unstructured":"Awad SS, Abdel Aziz RT, Mohammed SS. Management of resistant halo nevi. J Cosmet Laser Ther. 2018;9:1\u20134.","journal-title":"J Cosmet Laser Ther"},{"key":"430_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/dth.12326","volume":"29","author":"K Wang","year":"2016","unstructured":"Wang K, Wang Z, Huang W. Resolution of vitiligo following excision of halo congenital melanocytic nevus: a rare case report. Dermatol Ther. 2016;29:145\u20137.","journal-title":"Dermatol Ther"},{"key":"430_CR78","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1111\/j.1525-1470.2012.01781.x","volume":"30","author":"M Workman","year":"2013","unstructured":"Workman M, Sawan K, El Amm C. Resolution and recurrence of vitiligo following excision of congenital melanocytic nevus. Pediatr Dermatol. 2013;30:e166\u20138.","journal-title":"Pediatr Dermatol"},{"key":"430_CR79","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","volume":"32","author":"JS Pasricha","year":"1993","unstructured":"Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol. 1993;32:753\u20137.","journal-title":"Int J Dermatol"},{"key":"430_CR80","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/0019-5154.108040","volume":"58","author":"I Majid","year":"2013","unstructured":"Majid I, Imran S. Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: a 12-month follow-up study. Indian J Dermatol. 2013;58:113\u20136.","journal-title":"Indian J Dermatol"},{"key":"430_CR81","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1365-4632.2008.03660.x","volume":"47","author":"KU Schallreuter","year":"2008","unstructured":"Schallreuter KU, Kr\u00fcger C, W\u00fcrfel BA, et al. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol. 2008;47:743\u201353.","journal-title":"Int J Dermatol"},{"key":"430_CR82","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.det.2016.11.010","volume":"35","author":"PE Grimes","year":"2017","unstructured":"Grimes PE, Nashawati R. Depigmentation therapies for vitiligo. Dermatol Clin. 2017;35:219\u201327.","journal-title":"Dermatol Clin"},{"key":"430_CR83","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","volume":"151","author":"BG Cralglow","year":"2015","unstructured":"Cralglow BG, King BA. Tofacitinib citrate for the treatment of\u00a0vitiligo: a pathogenesis-directed therapy. JAMA Dermatol. 2015;151:1110\u20132.","journal-title":"JAMA Dermatol"},{"key":"430_CR84","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jaad.2017.02.049","volume":"76","author":"B Rothstein","year":"2017","unstructured":"Rothstein B, Joshipura D, Saralya A, et al. Treatment of\u00a0vitiligo\u00a0with the topical Janus kinase inhibitor ruxolitinib. J Am Acad Dermatol. 2017;76:1054\u201360.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-019-00430-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:33:10Z","timestamp":1585009990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-019-00430-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1007\/s40257-019-00430-0","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"25 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for the preparation of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Electra Nicolaidou, Styliani Mastraftsi, Vassiliki Tzanetakou. and Dimitrios Rigopoulos declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent for photographs used in this review was obtained from all individual patients and their parents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}